GB9716657D0
(en)
*
|
1997-08-07 |
1997-10-15 |
Zeneca Ltd |
Chemical compounds
|
GB9902461D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
GB0000626D0
(en)
*
|
2000-01-13 |
2000-03-01 |
Zeneca Ltd |
Chemical compounds
|
AU2001280461A1
(en)
*
|
2000-08-04 |
2002-02-18 |
Eli Lilly And Company |
Substituted pyrrole compounds and their use as spla2 inhibitors
|
JP2004523534A
(ja)
|
2000-12-20 |
2004-08-05 |
ブリストル−マイヤーズ スクイブ カンパニー |
ケモカイン受容体活性調節剤としての環状誘導体
|
JP2005506949A
(ja)
|
2000-12-20 |
2005-03-10 |
ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー |
ケモカイン受容体の調節剤としてのジアミン
|
CA2440803A1
(en)
|
2001-03-07 |
2002-09-12 |
Pfizer Products Inc. |
Modulators of chemokine receptor activity
|
US6730694B1
(en)
|
2001-07-20 |
2004-05-04 |
Eli Lilly And Company |
sPLA2 inhibitors
|
IL160642A0
(en)
*
|
2001-10-03 |
2004-07-25 |
Ucb Sa |
Pyrrolidinone derivatives
|
ATE325125T1
(de)
|
2002-09-06 |
2006-06-15 |
Janssen Pharmaceutica Nv |
Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
|
WO2004071449A2
(en)
|
2003-02-12 |
2004-08-26 |
Bristol-Myers Squibb Company |
Lactams as modulators of chemokine receptor activity
|
TW200508224A
(en)
|
2003-02-12 |
2005-03-01 |
Bristol Myers Squibb Co |
Cyclic derivatives as modulators of chemokine receptor activity
|
US7230133B2
(en)
|
2003-05-01 |
2007-06-12 |
Bristol-Myers Squibb Company |
Malonamides and malonamide derivatives as modulators of chemokine receptor activity
|
US7291615B2
(en)
|
2003-05-01 |
2007-11-06 |
Bristol-Myers Squibb Company |
Cyclic derivatives as modulators of chemokine receptor activity
|
SE0302035D0
(sv)
*
|
2003-07-09 |
2003-07-09 |
Biolipox Ab |
New compound
|
US7163937B2
(en)
|
2003-08-21 |
2007-01-16 |
Bristol-Myers Squibb Company |
Cyclic derivatives as modulators of chemokine receptor activity
|
PL380887A1
(pl)
*
|
2003-12-29 |
2007-04-02 |
Sepracor Inc. |
Pirolowe i pirazolowe inhibitory DAAO
|
US7288563B2
(en)
|
2004-02-19 |
2007-10-30 |
Bristol-Myers Squibb Company |
Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
|
US7230022B2
(en)
|
2004-02-19 |
2007-06-12 |
Bristol-Myers Squibb Company |
Substituted fused bicyclic amines as modulators of chemokine receptor activity
|
US7381738B2
(en)
|
2004-02-19 |
2008-06-03 |
Bristol-Myers Squibb Company |
Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
|
US7479496B2
(en)
|
2004-02-19 |
2009-01-20 |
Bristol-Myers Squibb Company |
Substituted spiro azabicyclics as modulators of chemokine receptor activity
|
US8481035B2
(en)
|
2004-04-27 |
2013-07-09 |
Northwestern University |
Methods for treating chronic pelvic pain syndrome with antibodies that binds MCP-1 or MIP-1A
|
US20080188473A1
(en)
*
|
2004-06-18 |
2008-08-07 |
Kristofer Olofsson |
Indoles Useful in the Treatment of Inflammation
|
ATE405549T1
(de)
|
2004-06-18 |
2008-09-15 |
Biolipox Ab |
Zur behandlung von entzündungen geeignete indole
|
ATE430132T1
(de)
*
|
2004-06-18 |
2009-05-15 |
Biolipox Ab |
Zur behandlung von entzündungen geeignete indole
|
US20060069123A1
(en)
*
|
2004-09-28 |
2006-03-30 |
Mingde Xia |
Substituted dipiperidine CCR2 antagonists
|
ATE503741T1
(de)
*
|
2005-01-14 |
2011-04-15 |
Chemocentryx Inc |
Heteroarylsulfonamide und ccr2
|
US7622583B2
(en)
*
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
US20090048285A1
(en)
*
|
2005-01-19 |
2009-02-19 |
Benjamin Pelcman |
Pyrrolopyridines Useful in the Treatment of Inflammation
|
US20100197687A1
(en)
*
|
2005-01-19 |
2010-08-05 |
Benjamin Pelcman |
Indoles Useful in the Treatment of Inflammation
|
CN101142185A
(zh)
|
2005-01-19 |
2008-03-12 |
比奥里波克斯公司 |
用于炎症治疗的吲哚
|
US20080249091A1
(en)
*
|
2005-01-19 |
2008-10-09 |
Benjamin Pelcman |
Indoles Useful in the Treatment of Inflammation
|
WO2006077412A1
(en)
*
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Thienopyrroles useful in the treatment of inflammation
|
CA2594773A1
(en)
*
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
EP1904066B1
(en)
|
2005-07-06 |
2018-05-23 |
Sunovion Pharmaceuticals Inc. |
COMBINATIONS OF ESZOPICLONE AND TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE OR TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE, for treating MENOPAUSE, perimenopause AND COGNITIVE DISORDERS
|
US20070203111A1
(en)
|
2006-01-06 |
2007-08-30 |
Sepracor Inc. |
Cycloalkylamines as monoamine reuptake inhibitors
|
CN104276955A
(zh)
|
2006-01-06 |
2015-01-14 |
赛诺维信制药公司 |
基于四氢萘酮的单胺再摄取抑制剂
|
ES2555315T3
(es)
|
2006-03-31 |
2015-12-30 |
Sunovion Pharmaceuticals Inc. |
Preparación de amidas y aminas quirales
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
CA2659060A1
(en)
*
|
2006-06-30 |
2008-01-10 |
Sepracor Inc. |
Fused heterocyclic inhibitors of d-amino acid oxidase
|
US20080058395A1
(en)
*
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
US7579370B2
(en)
*
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
US8519135B2
(en)
*
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
US7629351B2
(en)
|
2006-07-28 |
2009-12-08 |
Bristol-Myers Squibb Company |
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process
|
US7671062B2
(en)
|
2006-07-28 |
2010-03-02 |
Bristol-Myers Squibb Company |
Modulators of chemokine receptor activity, crystalline forms and process
|
US7687508B2
(en)
|
2006-07-28 |
2010-03-30 |
Bristol-Myers Squibb Company |
Cyclic derivatives as modulators of chemokine receptor activity
|
US8492405B2
(en)
|
2006-10-18 |
2013-07-23 |
Takeda Pharmaceutical Company Limited |
Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
CA2676432A1
(en)
*
|
2007-01-18 |
2008-07-24 |
Sepracor, Inc. |
Inhibitors of d-amino acid oxidase
|
MX2009012685A
(es)
|
2007-05-31 |
2009-12-14 |
Sepracor Inc |
Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
|
CA2692761C
(en)
|
2007-07-12 |
2013-04-30 |
Chemocentryx, Inc. |
Fused heteroaryl pyridyl and phenyl benzenesulfonamides as ccr2 modulators for the treament of inflammation
|
WO2010017418A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|
WO2010019796A1
(en)
*
|
2008-08-14 |
2010-02-18 |
Chemietek, Llc |
Heterocyclic amide derivatives as ep4 receptor antagonists
|
WO2011017634A2
(en)
*
|
2009-08-07 |
2011-02-10 |
Sepracore Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|
US8383812B2
(en)
|
2009-10-13 |
2013-02-26 |
Bristol-Myers Squibb Company |
N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
|
IL266751B
(en)
|
2016-11-23 |
2022-07-01 |
Chemocentryx Inc |
A method for the treatment of focal segmental tuberous sclerosis
|
EP4252629A3
(en)
|
2016-12-07 |
2023-12-27 |
Biora Therapeutics, Inc. |
Gastrointestinal tract detection methods, devices and systems
|
EP3554541B1
(en)
|
2016-12-14 |
2023-06-07 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
|
JP2020536919A
(ja)
|
2017-10-11 |
2020-12-17 |
ケモセントリックス, インコーポレイテッド |
Ccr2アンタゴニストによる巣状分節性糸球体硬化症の治療
|
KR20210095165A
(ko)
|
2018-11-19 |
2021-07-30 |
프로제너티, 인크. |
바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스
|
CN115666704A
(zh)
|
2019-12-13 |
2023-01-31 |
比奥拉治疗股份有限公司 |
用于将治疗剂递送至胃肠道的可摄取装置
|